Corcept Therapeutics
CORT
CORT
215 hedge funds and large institutions have $1.38B invested in Corcept Therapeutics in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 78 increasing their positions, 75 reducing their positions, and 23 closing their positions.
Holders
215
Holders Change
+3
Holders Change %
+1.42%
% of All Funds
4.93%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
27
Increased
78
Reduced
75
Closed
23
Calls
$8.13M
Puts
$25M
Net Calls
-$16.8M
Net Calls Change
-$17.9M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$162M |
2 |
2
BlackRock
New York
|
$223M |
3 |
ISL
3
Ingalls & Snyder LLC
New York
|
$115M |
4 |
4
Fuller & Thaler Asset Management
San Mateo,
California
|
$6.89M |
5 |
5
KBC Group
Brussels,
Belgium
|
$5.8M |